Grifols, as announced in a recent press release, has officially launched FESILTY™ (fibrinogen, human-chmt) in the United States. The therapy is approved to treat sudden,
As reported by the BBC, landmark advance in type 1 diabetes care has been reached with the introduction of teplizumab, the first treatment shown to
Further to the WHO’s official confirmation of an outbreak of 300 Ebola cases as of May 2026, health authorities in the Democratic Republic of the
Every single day, the average person inhales thousands of microscopic fungal spores. For most of us, our immune systems destroy these tiny invaders before they
As reported on Scientific American, a growing body of research suggests that Alzheimer’s disease progression is driven by a complex interplay between beta-amyloid plaques and
Editor’s Note: This story is a continuation of Jenny Decker’s global sailing voyage. To see the original article, please click here. Jenny Decker left Hawaii in
Recently at the World Orphan Drug Conference in Boston, Patient Worthy had the opportunity to meet with Dave Pearce PhD, Chair of International Rare Disease
As reported on Yahoo News, a combination therapy involving nivolumab (Opdivo) from Bristol Myers Squibb and cabozantinib (Cabometyx) from Exelixis has demonstrated substantial clinical benefit
Editor’s Note: This article was shared with us by our friends at the Courageous Parents Network. To see the article in its original format, please
In a recent statement, CONNECTA Therapeutics, a biotechnology company focused on disorders of the central nervous system, has announced the start of its Phase IIa
As seen in the CDC’s recent reports, 0.6 per 100,000 people were hospitalized in mid-April with confirmed hospital admissions averaging between 800 to 900 in
As reported on Medscape, global phase 3 clinical trial suggests that veligrotug, an investigational monoclonal antibody targeting the insulin-like growth factor‑1 receptor (IGF‑1R), may offer
As reported on Becker’s Hospital Review, the U.S. Food and Drug Administration (FDA) has issued updated guidance targeting how telehealth companies promote compounded medications, particularly
As reported on CNET, parents and caregivers now have a new option to help monitor children’s blood sugar levels at home. The US Food and
As reported on Pharmaceutical Technology, the US Food and Drug Administration (FDA) has approved a new adjuvant treatment option for adults with clear cell renal
As reported on MedCity News, the U.S. Food and Drug Administration (FDA) has introduced a new regulatory pathway that could reshape how treatments are developed
As reported on Business Wire, Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application for
I grew up believing health was something you could control if you were disciplined enough. In my Chinese immigrant family, my father talked constantly about
Answers often begin with asking the right questions. Understanding how myelofibrosis with anemia is diagnosed can help patients and caregivers feel more informed, prepared, and empowered throughout the diagnostic journey. Awareness starts with knowledge. 💙
We want to hear from you! Click the link below to share -
bit.ly/3VuxFDV
#Myelofibrosis #AnemiaAwareness #PatientWorthy
💙 Knowledge is power, and community makes the journey easier.
Living with myelofibrosis and anemia can bring questions, challenges, and uncertainty. Understanding the symptoms and causes of these conditions can help patients recognize changes in their health, seek appropriate care, and have more informed conversations with their healthcare team.
✨ The more we learn, the better we can advocate for ourselves and each other.
#Myelofibrosis #Anemia #bloodcancerawareness #PatientWorthy #RareDiseaseCommunity #patientadvocacy #StrongerTogether #HealthAwareness #youarenotalone
Patients Needed: Myelofibrosis with Anemia
Patient Worthy is looking for individuals living with myelofibrosis and anemia who are interested in sharing their experiences. Your story can help raise awareness, provide valuable insights, and remind others in the community that they are not alone.
Be the reason someone feels seen, supported, and inspired.
If you're interested in learning more or joining the conversation, visit patientworthy.com for the latest information. If you have a story to share, click here: bit.ly/4dV7gru or click the link in our bio.
#Myelofibrosis #Anemia #bloodcancer #PatientStory #shareyourstory #PatientWorthy #PatientVoice #RareDiseaseCommunity
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
